AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06609967 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: application of PRF
Description: PRF will be randomly administered into one group of patients undergoing any extractions group A (Right after the extraction) Group B will be a control group in which extraction sockets will be left to heal with the natural blood clot. Consenting patients will be assigned into groups randomly and not informed which group they were placed into. The PRF will be administered obtained from a tube of 10 ml blood and no material will be placed in the control group. The progress of healing and post-operative complications will be tracked over a period of 7 days with patients being called for follow-up on days 3, 5 and 7
Study NCT06609967 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: application of conventional surgicel
Description: it will be a control group in which extraction sockets will be left to heal with the natural blood clot.
Study NCT06610318 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: imagery rescripting
Description: This condition has three stages. In the first stage, participants were asked to select their most distressing memory related to their appearance (not physical or sexual trauma). They were asked to visualize the selected memory, in detail, as if it were happening to them again. Then, interventionists used a downward arrow technique to identify two-to-three maladaptive core schema. In the second stage, participants were asked to identify a real or imagined trusted adult. Then, they were asked to imagine what their younger self might need to cope with or feel calmer in the situation of their selected memory. In the third stage, the participant was instructed to imagine asking the trusted adult for what they need and to imagine the trusted adult providing their selected interventions and describe how they feel afterwards. These procedures were then repeated with participants' most distressing memory related to eating. This session was remote delivered via Zoom.
Study NCT06610318 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: nutrition education
Description: The active control condition consisted of a time- and attention-matched general nutrition education session. The curriculum for this intervention included information from the United States Department of Agriculture's Dietary Guidelines (e.g., food labels, describing the benefits of macronutrients). This session was remote delivered using Zoom.
Study NCT06609785 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The volunteers successively completed both high intensity interval training (HIIT)and continuous aerobic training (CAT) under the supervision of a professional coach, and the interval between each type of exercise was 7 days. Each training session was initiated with a brief 2-minute standardized warm-up, followed by 20 minutes of cycling consisting of periods of 2 minutes at 80-95% maximal heart rate (HRmax) separated by 2 minutes of active recovery for the HIIT group or 20 minutes of cycling at 60-80% of HRmax for the CAT group.
Study NCT06610123 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Caffeine and Resistance training
Description: Acute caffeine intake (3 mg/kg) prior each resistance training session of a 8 weeks training program.
Study NCT06610123 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo and Resistance training
Description: Acute placebo intake (3 mg/kg of maltodextrin) prior each resistance training session of a 8 weeks training program.
Study NCT06528951 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Phase ( 6Weeks)
Description: The participants will perform a control phase of six weeks of resistance training using the same volume for the upper (160 repetitions) and lower limbs (230 repetitions), with relative intensities ranging from 40% to 70% of 1RM. The training sequence will be the following: i) 10 minutes of warmup walking on the treadmill, ii) 1-3 sets of 5-10 repetitions at 50-70% of 1RM in the leg press, iii) 1-3 sets of 5-10 repetitions at 40-60% 1RM in the chest press, iv) 1-3 sets of 6-10 repetitions in the sit-to-stand exercise, v) 1-3 sets of 5-7 repetitions in the 1- kg medicine ball throw, and vi) 5 minutes walking on the treadmill.
Study NCT06528951 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 15% increase in resistance training volume (10 Weeks)
Description: The participants will perform ten weeks of resistance training, increasing their initial volume by 15% (upper limbs - 184 repetitions; lower limbs - 268 repetitions). The number of sets will range from 1 to 3, and the relative intensities from 40% to 70% 1RM. The training sequence will be the following: i) 10 minutes of warmup walking on the treadmill, ii) 1-3 sets of 3-10 repetitions at 50-70% of 1RM in the leg press, iii) 1-3 sets of 3-10 repetitions at 40-60% 1RM in the chest press, iv) 1-3 sets of 4-10 repetitions in the sit-to-stand exercise, v) 1-3 sets of 3-8 repetitions in the 1- kg medicine ball throw, and vi) 5 minutes walking on the treadmill.
Study NCT06528951 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 30% increase in resistance training volume (10 Weeks)
Description: The participants will perform ten weeks of resistance training, increasing their initial volume by 30% (upper limbs - 208 repetitions; lower limbs - 300 repetitions). The number of sets will range from 1 to 3, and the relative intensities from 40% to 70% 1RM. The training sequence will be the following: i) 10 minutes of warmup walking on the treadmill, ii) 1-3 sets of 4-10 repetitions at 50-70% of 1RM in the leg press, iii) 1-3 sets of 4-10 repetitions at 40-60% 1RM in the chest press, iv) 1-3 sets of 5-10 repetitions in the sit-to-stand exercise, v) 1-3 sets of 4-7 repetitions in the 1- kg medicine ball throw, and vi) 5 minutes walking on the treadmill.
Study NCT06528951 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: One group that performed 15% more volume and increased to 30% (10 Weeks)
Description: The participants will perform 10 weeks of resistance training. The group that performed a 15% volume will now increase more by 15% and perform 30% (upper limbs - 208 repetitions; lower limbs - 300 repetitions). The number of sets will range from 1 to 3, and the relative intensities from 40% to 70% 1RM. The training sequence will be the following: i) 10 minutes of warmup walking on the treadmill, ii) 1-3 sets of 4-10 repetitions at 50-70% of 1RM in the leg press, iii) 1-3 sets of 4-10 repetitions at 40-60% 1RM in the chest press, iv) 1-3 sets of 5-10 repetitions in the sit-to-stand exercise, v) 1-3 sets of 4-7 repetitions in the 1- kg medicine ball throw, and vi) 5 minutes walking on the treadmill.
Study NCT06528951 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: One group that performed 30% more volume and increased to 45% (10 Weeks).
Description: The participants will perform 10 weeks of resistance training. The group that performed a 30% volume will now increase more by 15% and perform 45% (upper limbs - 232 repetitions; lower limbs - 334 repetitions). The number of sets will range from 1 to 3, and the relative intensities from 40% to 70% 1RM. The training sequence will be the following: i) 10 minutes of warmup walking on the treadmill, ii) 1-3 sets of 3-10 repetitions at 50-70% of 1RM in the leg press, iii) 1-3 sets of 3-10 repetitions at 40-60% 1RM in the chest press, iv) 2-3 sets of 8 repetitions in the sit-to-stand exercise, v) 2-3 sets of 8 repetitions in the 1- kg medicine ball throw, and vi) 5 minutes walking on the treadmill.
Study NCT06528951 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control group ( 29 Weeks)
Description: The participants in the control group will maintain their regular daily activities without performing any form of physical exercise.
Study NCT06453408 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Punción seca con aguja retráctil
Description: The placebo dry needling protocol will be performed in the same position, with identical antiseptic measures and the same number of simulated incisions as the real dry needling protocol, using DONGBANG AcuPrime® 0.30 x 30mm blunt-tipped placebo needles with a retractable handle. These needles simulate the sensation of needle contact without penetrating the skin. The therapist will hold the needle and guide tube, pressing the tube against the skin and simulating needle manipulation. Changes in pressure direction will mimic the real technique. The protocol will end with compression using an alcohol swab and an upper trapezius stretch.~Participants in both groups will receive the same information about the sensations of the dry needling procedure. At the beginning, they will be informed that they may or may not feel the needle insertion. They will also be told that the physiotherapist will manually manipulate the needle multiple times during the procedure.
Study NCT06453408 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Punción seca con aguja normativa.
Description: To perform the actual SP, patients shall be asked to lie prone with arms close to the body. The dry needling shall be performed with a 0,30 × 30 mm DN needle (APS Regular Agupunt) with a guide tube. The therapist shall first clean the area with alcohol. The trapezius muscle is then firmly grasped with a clamp between the thumb and index finger, so that the needle is directed deep into the index finger until the tip of the needle is felt to be approaching (33). This procedure involves an approximate insertion of the needle to a depth of 30 mm and ensures the intramuscular penetration necessary for dry needling. Puncture of the PGM shall be performed using the Hong technique (34), performing up to 12 inlets and outlets, at a frequency of 1 Hz. When the needle is withdrawn, the area is firmly compressed with cotton wool for 60 seconds. Finally, the upper trapezius muscle is stretched, following the technique originally described by Simons (35).
Study NCT05597774 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory + expiratory muscle training group
Description: Participants will perform an inspiratory and expiratory muscle training including warm-up, recovery between intervals and return to calm.
Study NCT05597774 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Inspiratory + expiratory muscle training sham group
Description: Participants will perform an inspiratory and expiratory muscle training including warm-up, recovery between intervals and return to calm.
Study NCT05597774 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise training program
Description: Participants will perform a cardiovascular exercise program including warm-up, recovery between intervals and return to calm by cycloergometer.
Study NCT05597774 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Exercise training program
Description: Participants will perform a cardiovascular exercise program including warm-up, recovery between intervals and return to calm by cycloergometer.
Study NCT05445895 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Renexin CR 200/160mg
Description: Renexin CR 200/160mg will be added to Aspirin 100mg
Study NCT05445895 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Plavix 75mg
Description: Plavix 75mg will be added to Aspirin 100mg
Study NCT06209333 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Patient Education
Description: Standard Patient Education will take approximately 20 minutes. Within the scope of standard patient education, some recommendations will be made to the patient to lose weight, drink sufficient water, avoid consuming caffeinated foods and beverages, acidic/carbonated or alcoholic beverages, spicy/acidic foods, and quit smoking. Patients will be evaluated on the day they receive standard patient training (before receiving this training) and 10 weeks after the training.
Study NCT06209333 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: bladder training
Description: Interval urination in bladder training in bladder training will be determined according to the bladder diaries filled in by the patients. If the patient is able to do it, bladder education will be improved by increasing the interval urination in bladder training. A total of 5 sessions of bladder training will be applied to patients, the first session of which will be face-to-face. Within the scope of Bladder Training, the patient will be given information about bladder, pelvic floor, incontinence and relaxation techniques. The patient will be asked to fill out a 3-day bladder diary before starting bladder training, and an appropriate progressive timed voiding program will be drawn according to the bladder diaries, and the patient will be given a training brochure to implement this program.
Study NCT06209333 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pelvic floor exercise
Description: This training will take between 45 and 60 minutes.Within the scope of exercise training, patients will be taught 3 types of contractions: maximal (fast), slow and submaximal contractions. The patient will be asked to continue the maximum and submaximal contraction for 1-2 seconds, and to continue the Deceleration contraction for 3-10 seconds. These contractions will be performed in different positions such as supine, lying on the side, sitting, crawling, squatting and standing, specifically for the pelvic floor November muscle strength of the patient. These exercises will be performed every day and each type of contraction (maximal, slow and submaximal contraction) will be performed 8-12 repetitions, 3 sets per day. Progress will be achieved with follow-ups.
Study NCT05749484 — intervention group
Intervention type: OTHER
Intervention: NCRT+TME
Description: The eligible patients who voluntarily sign the consent form will undergo NCRT and TME according to treatment guidelines.
Study NCT06422468 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: FibriCheck recordings
Description: PPG, ACC, GYR, ECG and sound measurements
Study NCT04874285 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: HA
Description: hyaluronic acid, alpha-lipoic acid, vitamin D and vitamin B6
Study NCT04850677 — intervention group
Intervention type: OTHER
Intervention: Observational Cohort
Description: Observational study
Study NCT04945759 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Isokinetick Exercise, Aussie Current, Russion Current, Plasebo Electirical Stimulasyon
Description: Evaluation and treatment will be done with the Cybex humac device.
Study NCT04945759 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Isokinetick Exercise, Aussie Current, Russion Current, Plasebo Electirical Stimulasyon
Description: Evaluation and treatment will be done with the Cybex humac device.
Study NCT04945759 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Isokinetick Exercise, Aussie Current, Russion Current, Plasebo Electirical Stimulasyon
Description: Evaluation and treatment will be done with the Cybex humac device.
Study NCT05980728 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: No Intervention
Study NCT05930652 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Psychological tests and psychosocial questionnaires
Description: Assessment of psychological functioning (including well-being, mental health conditions, coping skills), and socio-demographics, academic performance, home, relationships, general health, habits, and attitudes.
Study NCT04738981 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UC-MSC
Description: UC-MSC, iv, 1×10\^6 cells/kg, once a week, for 4 weeks.
Study NCT04738981 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anti-CD25 mAb
Description: Anti-CD25 mAb, iv, 20mg，twice in first week and once a week thereafter, for 4 weeks.
Study NCT04738981 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-CD25 mAb
Description: Anti-CD25 mAb, iv, 20mg，twice in first week and once a week thereafter, for 4 weeks.
Study NCT05971459 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Improvised Active Music Therapy
Description: During the music improvisation process, the accredited music therapist will carefully listen to the participant's initial musical expression, including tempo, rhythmic structure, dynamics, and beat. The accredited music therapist will then join, reflecting or confirming aspects of the participant's musical expression using standard music therapy improvisation techniques such as mirroring, matching, dialoguing, and containing on their electronic instrument. By comparing the participant's and therapist's musical responses over the sessions, it will be possible to identify note frequency, velocity of movement, synchronization, and acquisition of rhythmic complexity.
Study NCT06360822 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ED-LCS
Description: This is a lung cancer educational intervention for patients in the emergency department.
Study NCT05751746 — intervention group
Intervention type: DRUG
Intervention: Magnesium sulfate
Description: Magnesium sulfate will be administered following a protocol that obstetricians already use in our hospital.
Study NCT05971459 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Improvised Active Music Therapy
Description: During the music improvisation process, the accredited music therapist will carefully listen to the participant's initial musical expression, including tempo, rhythmic structure, dynamics, and beat. The accredited music therapist will then join, reflecting or confirming aspects of the participant's musical expression using standard music therapy improvisation techniques such as mirroring, matching, dialoguing, and containing on their electronic instrument. By comparing the participant's and therapist's musical responses over the sessions, it will be possible to identify note frequency, velocity of movement, synchronization, and acquisition of rhythmic complexity.
Study NCT05937763 — intervention group
Intervention type: OTHER
Intervention: Staffing model
Description: Staffing the hospitals emergency department offload zone with a PCP or RN or current workflow.
Study NCT05682755 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chidamide
Description: initial time：platelet count ≥50×10\^9/L after allo-HSCT initial dose: 5 mg oral twice weekly initial adjustment: according to the platelet count tested weekly platelet count ≥50×10\^9/L-increased by 5 mg 20×10\^9/L≤ platelet count \<50×10\^9/L-remains unchanged platelet count \<50×10\^9/L- reduced by 5 mg maximum dose: 20 mg oral twice weekly terminal time: 180 days after allo-HSCT
Study NCT04811066 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Description: Transcranial electrical stimulation device. A weak direct electrical current, up to 2 mA, is passed between two electrodes placed on the scalp. Electrodes are housed in 35 cm2 sponges saturated with 4 ml of saline solution (0.9 % NaCl) per side, per pad.~Stimulation is phased in with a 30-second ramp up of the electrical current to the specified stimulation parameters. Following the specified stimulation period, the current is phased-out with a ramp down of the current. For sham stimulation, the ramp-up and ramp-down periods are retained, but stimulation is switched off during the specified stimulation period.
Study NCT04811066 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial direct current stimulation
Description: Transcranial electrical stimulation device. A weak direct electrical current, up to 2 mA, is passed between two electrodes placed on the scalp. Electrodes are housed in 35 cm2 sponges saturated with 4 ml of saline solution (0.9 % NaCl) per side, per pad.~Stimulation is phased in with a 30-second ramp up of the electrical current to the specified stimulation parameters. Following the specified stimulation period, the current is phased-out with a ramp down of the current. For sham stimulation, the ramp-up and ramp-down periods are retained, but stimulation is switched off during the specified stimulation period.
Study NCT04973644 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Remote monitoring devices+Internet management platform
Description: Remote monitoring devices collects blood glucose, total cholesterol, serum ketones and serum uric acid,then upload data to the platform.
Study NCT06074276 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food: whole almonds
Description: 60 grams or (\~2 oz) will be consumed 5 times per week.
Study NCT06074276 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Food: non-nut snack
Description: Protein and calorie matched non-nut-based food will be consumed 5 times per week by mouth
Study NCT05610202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB3702 tablets
Description: TQB3702 tablets are selective BTK inhibitors.
Study NCT04840199 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letermovir 240 MG Oral Tablet
Description: 240 mg tablets. Administered orally as two tablets once daily with or without food.
Study NCT04840199 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letermovir 480 MG Oral Tablet
Description: 480 mg tablet. Administered orally as one tablet once daily with or without food.
Study NCT04840199 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination ART
Description: ART (antiretroviral therapy) medications will be prescribed by participants' health care providers. ARV medications will not be provided by the study.
Study NCT04840199 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Combination ART
Description: ART (antiretroviral therapy) medications will be prescribed by participants' health care providers. ARV medications will not be provided by the study.
Study NCT05448495 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Posterior TAP block
Description: Using high-frequency linear ultrasound probe, a total volume of 24 ml (20 ml isobaric bupivacaine 0.5% + 2 ml dexmedetomidine \[0.5 mcg\\kg\] + 2ml dexamethasone \[0.1mg\\kg)\] will be injected at the plane between internal oblique and transversus abdominis near the aponeurosis at the posterior axillary line.
Study NCT05448495 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ESPB
Description: Using high-frequency linear ultrasound probe, a total volume of 24 ml (20 ml isobaric bupivacaine 0.5% + 2 ml dexmedetomidine \[0.5 mcg\\kg\] + 2ml dexamethasone \[0.1mg\\kg)\] will be injected at T9 erector spinae plane